Clinical Trial Detail

Contact

Missing content? – Request curation!

Request curation for specific Genes, Variants, or PubMed publications.

Have questions, comments, or suggestions? - Let us know!

Email us at : ckbsupport@genomenon.com

NCT ID NCT05590377
Title A Study of Modakafusp Alfa Together With Daratumumab Adults With Relapsed or Refractory Multiple Myeloma
Acronym iinnovate-3
Recruitment Completed
Gender both
Phase Phase Ib/II
Variant Requirements No
Sponsors Takeda
Indications
Therapies
Age Groups: adult | senior
Covered Countries USA | FRA | ESP | CAN | AUS


No variant requirements are available.